These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4992362)

  • 1. Fate of intravenously administered zinc chelates in man.
    Rosoff B; Hart H; Methfessel AH; Spencer H
    J Appl Physiol; 1971 Jan; 30(1):12-6. PubMed ID: 4992362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism and toxicity of therapeutic chelating agents. 3. Effect of EDTA and DTPA on the excretion of endogenous zinc].
    Havlicek F
    Strahlentherapie; 1967 Oct; 134(2):296-305. PubMed ID: 4970734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism and toxicity of therapeutic chelating agents. 4. Excretion and metabolic degradation of EDTA and DTPA].
    Havlícek F; Bohne F; Zorn H
    Strahlentherapie; 1968 Nov; 136(5):604-8. PubMed ID: 4974440
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and prolonged tissue retention of liposome-encapsulated chelating agents.
    Rahman YE; Rosenthal MW; Cerny EA; Moretti ES
    J Lab Clin Med; 1974 Apr; 83(4):640-7. PubMed ID: 4206355
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism and toxicity of therapeutic chelating agents. I. Comparative studies on the excretion of EDTA and DTPA in the rat urine].
    Harmuth-Hoene AE
    Strahlentherapie; 1967 Sep; 134(1):110-22. PubMed ID: 4967657
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of the Ca-complexes of aminopolycarboxylic acids on the excretion and distribution of zinc].
    Eybl V; Sýkora J; Mertl F
    Z Gesamte Exp Med Einschl Exp Chir; 1970 Aug; 152(4):274-83. PubMed ID: 4995887
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chelating agents on the removal of zinc-65 in man.
    Spencer H; Rosoff B
    Health Phys; 1966 Apr; 12(4):475-80. PubMed ID: 4960023
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
    Rahman YE; Rosenthal MW; Cerny EA
    Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism and toxicity of therapeutic chelating agents. II. Effect of DTPA on the intestinal absorption of zinc].
    Bohne F; Nigrović V; Harmuth-Hoene AE
    Strahlentherapie; 1967 Oct; 134(2):293-5. PubMed ID: 5598697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism and toxicity of therapeutic chelating agents. 8. Excretion of sodium, potassium, magnesium and zinc].
    Dvorak P
    Strahlentherapie; 1970 May; 139(5):611-8. PubMed ID: 4994080
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of EDTA, histidine and acetylsalicylic acid to zinc-protein complex in intestinal content, intestinal mucosa and blood plasma.
    Suso FA; Edwards HM
    Nature; 1972 Mar; 236(5344):230-2. PubMed ID: 4623207
    [No Abstract]   [Full Text] [Related]  

  • 12. The retention and distribution of 241Am and 65Zn, given as DTPA chelates in rats and of [14C]DTPA in rats and beagles.
    Stevens W; Bruenger FW; Atherton DR; Buster DS; Howerton G
    Radiat Res; 1978 Aug; 75(2):397-409. PubMed ID: 102009
    [No Abstract]   [Full Text] [Related]  

  • 13. Human zinc metabolism: advances in the modeling of stable isotope data.
    Miller LV; Krebs NF; Hambidge KM
    Adv Exp Med Biol; 1998; 445():253-69. PubMed ID: 9781394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary EDTA and cadmium on absorption, excretion and retention of orally administered 65Zn in various tissues of zinc-deficient and normal goats and calves.
    Powell GW; Miller WJ; Blackmon DM
    J Nutr; 1967 Oct; 93(2):203-12. PubMed ID: 4964051
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption of 51Cr-EDTA in ulcerative colitis following rectal instillation.
    Rask-Madsen J; Schwartz M
    Scand J Gastroenterol; 1970; 5(5):361-8. PubMed ID: 4989516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Decorporation of radionuclides. (Comparative studies with deferoxamine B and diethylenetriamine pentaacetic acid)].
    Nigrovic V; Catsch A
    Strahlentherapie; 1965 Oct; 128(2):283-7. PubMed ID: 5884887
    [No Abstract]   [Full Text] [Related]  

  • 17. Intestinal permeability in inflammatory bowel disease.
    Casellas F; Aguadè S; Molero J
    Am J Gastroenterol; 1986 Jun; 81(6):502. PubMed ID: 3085477
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution and retention of 169-YbCl3, 169-Yb-EDTA and 169-Yb-DTPA injected intravenously in the rat.
    Baltrukiewiez Z; Burakowski T; Pogorzelska-Lis M
    Acta Physiol Pol; 1975; 26(2):205-12. PubMed ID: 807085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of radiozinc chelates in the mammal organism].
    Catsch A; Du Khuong Le
    Strahlentherapie; 1966 Aug; 130(4):557-66. PubMed ID: 5996855
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of technetium-labeled chelating compounds for the evaluation of their penetration into the dentin].
    Pawlicka H; Ogiński M
    Stomatol DDR; 1984 Jun; 34(6):321-6. PubMed ID: 6435290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.